Feature | Vendor Neutral Archive (VNA) | January 31, 2020 | By Melinda Taschetta-Millane

The Role of AI in VNA’s Growth

This feature originally ran as an introduction to the Vendor Neutral Archives (VNA) comparison chart in the January/February 2020 issue. You can view the chart here.

GE Centricity Pacs

Photo courtesy of GE Healthcare

The vendor neutral archive (VNA) market continues to grow, as does the amount of patient data being collected. However, today’s VNAs go beyond simply storing and distributing images. 

According to Market Reports World,[1] the global VNA and picture archive and communications system (PACS) market was estimated at $3.28 billion in 2017. The market is expected to register a compound annual growth rate (CAGR) of 5.9 percent during the forecast period — 2018 to 2023. North America accounted for the largest market share, making up approximately 60 percent of the global market share in 2017, while the Europe region was estimated to register the fastest CAGR through the forecast period of 2018-2023.

The demand for image archiving is rising, but PACS appears to still dominate over VNA, generating most of the revenue from the PACS replacements, according to the report. PACS systems are defined as storing data per the DICOM standard to maintain uniformity, and this internal format for storing data varies from company to company. However, VNA helps in centralized storage and the universalization of the image format. This need continues to grow, making the VNA market one of the fastest growing areas in information technology.

ResearchAndMarkets.com[2] reports that the factors driving the market growth include the increasing demand for the universalization of medical image archiving, reducing data storage costs, high-level integration with the electronic health records (EHR) industry and compatibility of VNA with older data archival systems.

“In today’s healthcare systems, information-based decision making is crucial for delivering quality care and maintaining efficiency in health management,” the report states. “Patient data must be available for effective decision-making. Though the information exists in various systems across numerous healthcare providers, it is not readily available to the clinicians. Hence, the integration of VNA or PACS with the EHR systems is crucial for the clinicians in effective decision-making. With the absence of VNA, large volumes of enterprise patient content are floating around in departmental silos, file systems which would ultimately lead to care decision made with incomplete information.”

The EHR trend began long ago, its growth accelerated by various government initiatives and programs across developed and developing nations. This adoption continues to grow globally, which helps to make content more readily available to clinicians. The report states that the benefits associated with the platform are driving the market.

AI’s Role in VNA

As with most things, AI is playing a role in the future and growth of the VNA market. At the 2019 Radiological Society of North America’s (RSNA) annual meeting, it was apparent from the vastly expanded AI Showcase that AI is a force to reckon with. It is a central point for all the technology to funnel through that facilities are already working with, giving the them one central point to have an HL7 interface to provide a framework for working through a VNA.

There is a convergence of these technologies coming together. ITN Editorial Contributor Greg Freiherr used the following analogy to describe this merger: “They are like snowballs rolling down a hill, gathering momentum while also gathering substance. And, they also are converging,” he said. “They are helping to solve real-world problems.”

For example, GE is taking a very broad strategy to this approach; the company is looking at Centricity PACS, which is its own system, and they are building an open AI orchestrator to run in the background. The idea is to bring in algorithms that are not necessarily their own. GE’s goal is to have more than a dozen next year, which they can integrate and use an orchestrator to keep it running in the background. Although for now this is designed for the PACS, GE says eventually they will broaden this into other PACS and VNAs as well, moving into specific hubs, linking to different machines. This will allow the focus to be specifically on the algorithms that are necessary to run off those machines, without being focused on the machine itself.

 

References:

1. Market Reports World, Global Vendor Neutral Archive (VNA) & PACS Market - Segmented by Application, Delivery Mode, Usage Model, Player type and Geography - Growth, Trend and Forecast (2018 - 2023), www.marketreportsworld.com/global-vendor-neutral-archive-vna-pacs-market-12343552. Accessed Jan. 13, 2020.

2. ResearchAndMarkets.com, Vendor Neutral Archive (VNA) and PACS - Market Analysis, Trends, and Forecasts, https://www.researchandmarkets.com/reports/4806437/vendor-neutral-archive-vna-and-pacs-market#pos-1. Accessed Jan. 13, 2020.

 

Related content:

Vendor Neutral Archives (VNA) Comparison Chart

Related Content

Overall Excellence Finalist/Multi-platform Package of the Year for its coverage of the Pandemic’s Toll on Radiology, National

Overall Excellence Finalist/Multi-platform Package of the Year for its coverage of the Pandemic’s Toll on Radiology, National

Feature | Imaging Technology News - ITN | May 17, 2021 | By Melinda Taschetta-Millane
SmartXR uses a unique combination of hardware and AI-powered software to lighten radiographers’ workloads and provide image acquisition support.

SmartXR uses a unique combination of hardware and AI-powered software to lighten radiographers’ workloads and provide image acquisition support. 

Feature | Digital Radiography (DR) | May 04, 2021 | By Melinda Taschetta-Millane
The COVID-19 pandemic brought about an uptick in
A 63-year-old multiple #myeloma patient, with skeletal pain. New #FDG avid axillary #lymphadenopathy 62 days (9 weeks) after second #mRNA #vaccination dose. Image used with permission of the Radiological Society of North America (#RSNA)

A 63-year-old multiple myeloma patient, with skeletal pain. New FDG avid axillary lymphadenopathy 62 days (9 weeks) after second mRNA vaccination dose. Image used with permission of the Radiological Society of North America (RSNA)

Feature | Coronavirus (COVID-19) | April 29, 2021 | By Melinda Taschetta-Millane
Overview of the scaphoid fracture detection pipeline, which consisted of a segmentation and detection convolutional neural network (CNN). A class activation map is calculated and visualized as a heatmap for fracture localization. Image courtesy of Radiological Society of North America

Overview of the scaphoid fracture detection pipeline, which consisted of a segmentation and detection convolutional neural network (CNN). A class activation map is calculated and visualized as a heatmap for fracture localization. Image courtesy of the Radiological Society of North America

News | Artificial Intelligence | April 28, 2021
April 28, 2021 — An automated system that uses...
Examples of axial FLAIR sequences from studies within dataset A. From left to right: a patient with a 'likely normal' brain; a patient presenting an intraparenchymal hemorrhage within the right temporal lobe; a patient presenting an acute infarct of the inferior division of the right middle cerebral artery; and a patient with known neurocysticercosis presenting a rounded cystic lesion in the left middle frontal gyrus. Image courtesy of Radiological Society of North America

Examples of axial FLAIR sequences from studies within dataset A. From left to right: a patient with a 'likely normal' brain; a patient presenting an intraparenchymal hemorrhage within the right temporal lobe; a patient presenting an acute infarct of the inferior division of the right middle cerebral artery; and a patient with known neurocysticercosis presenting a rounded cystic lesion in the left middle frontal gyrus. Image courtesy of Radiological Society of North America

News | Artificial Intelligence | April 22, 2021
April 22, 2021 — An artificial intellige...
Spectral DLR enables improved assessment of lumen stenosis in the presence of calcified plaque. Interactive monochromatic image display enables improved opacification of the injected contrast with low keV images and reduced calcium blooming artifacts with high keV images

Spectral DLR enables improved assessment of lumen stenosis in the presence of calcified plaque. Interactive monochromatic image display enables improved opacification of the injected contrast with low keV images and reduced calcium blooming artifacts with high keV images. The range of monochromatic energy levels (35-135 keV) can be visualized in real time through an image slider in the application that can be integrated in to a PACS.

News | Cardiac Imaging | April 21, 2021
April 21, 2021 — Meeting the growing cardiovascular needs of healthcare providers today, ...